novartis glp 1 Metsera touts long-acting GLP-1 drug; strikes an AI deal GLP-1 | Summary
Description
These are the majority of the injuries alleged in the Ozempic lawsuit to date
Small animal clinical pharmacology
But over time, the benefits of improved health, increased mobility, reduced chronic disease burden, and enhanced self-image tend to accumulate
Support for this idea may come from an ongoing clinical trial where increased relative amounts of GIPR agonism (NNC00900389
